Big pharma, Partnering, Pharma

Genentech biotech deals Arrayit for drug discovery tool

Posted on 11 September 2013

Tags: , , ,

Genentech has entered into biotech deals with Arrayit to purchase a drug discovery tool for $138,000.

Arrayit Corporation reports that pharmaceutical giant Genentech has purchased Arrayit's patented technology to accelerate drug discovery, as part of the biotech deals.

Genentech purchased Arrayit's NanoPrint LM60 Microarrayer Platform including a manufacturing robot, printing pins and consumables for $138,000, as part of the biotech deals.

Genentech scientists employ Arrayit protein microarray technology to screen protein-protein interactions in a massively parallel manner as a means of speeding the discovery of new protein drugs.


Report: Asset Purchase Terms & Agreements

Report: Partnering Deals and Alliances with Genentech

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply